Arkolith/Insider Trading/NAVB/Form 4

Witter Malcolm G

DirectorNAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) · full profile →Form 4 · filed Sep 1, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 31, 2022Grant(A)3K—$0159K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 30, 2022Buy(P)115——115
Aug 30, 2022Buy(P)115——115

Transaction Codes

A
Grant / award
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-22-021742) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML